ArticleOncotarget2014

Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.

Gian Matteo Rigolin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.